JP2017516834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516834A5 JP2017516834A5 JP2016571251A JP2016571251A JP2017516834A5 JP 2017516834 A5 JP2017516834 A5 JP 2017516834A5 JP 2016571251 A JP2016571251 A JP 2016571251A JP 2016571251 A JP2016571251 A JP 2016571251A JP 2017516834 A5 JP2017516834 A5 JP 2017516834A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticles
- kda
- matrix agent
- pharmaceutical composition
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14001974.6 | 2014-06-06 | ||
| EP14001974 | 2014-06-06 | ||
| PCT/EP2015/000974 WO2015185180A1 (en) | 2014-06-06 | 2015-05-12 | Antigen-loaded chitosan nanoparticles for immunotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017516834A JP2017516834A (ja) | 2017-06-22 |
| JP2017516834A5 true JP2017516834A5 (cg-RX-API-DMAC7.html) | 2018-06-21 |
| JP6730937B2 JP6730937B2 (ja) | 2020-07-29 |
Family
ID=50897334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571251A Active JP6730937B2 (ja) | 2014-06-06 | 2015-05-12 | 免疫療法のための抗原負荷キトサンナノ粒子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10369217B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3151856B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6730937B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106456746B (cg-RX-API-DMAC7.html) |
| AR (1) | AR100745A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015271295B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2951063C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2754507T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL249357B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015185180A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3698773A1 (en) | 2019-02-21 | 2020-08-26 | Università degli Studi di Parma | Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination |
| CN110974805A (zh) * | 2019-12-23 | 2020-04-10 | 中国科学院海洋研究所 | 具有增强抗原提呈细胞提呈抗原作用的壳聚糖衍生物纳米粒及制备 |
| GB202018665D0 (en) * | 2020-11-26 | 2021-01-13 | Provost Fellows And Scholars Of Trinity College Dublin | Immunotherapy for cancer |
| WO2023168541A1 (en) * | 2022-03-09 | 2023-09-14 | Shenzhen Genius Biotech Service Co., Ltd. | Chitosan nanoparticles (cnps) and preparation method thereof |
| WO2024083221A1 (zh) * | 2022-10-21 | 2024-04-25 | 北京安必奇生物科技有限公司 | 一种黏膜给药制剂及其制备方法和应用 |
| CN119506406A (zh) * | 2023-08-24 | 2025-02-25 | 康希诺生物股份公司 | 一种表征吸入疫苗性能的方法 |
| WO2025209535A1 (en) * | 2024-04-03 | 2025-10-09 | Suzhou Xinxin Biopharma Co., Ltd | Compositions and associated methods for chitosan-based nano-carriers for therapeutic agents and their applications |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
| US8137697B1 (en) * | 2004-10-05 | 2012-03-20 | Gp Medical, Inc. | Nanoparticles for protein/peptide delivery and delivery means thereof |
| ES2259914B1 (es) * | 2005-03-14 | 2007-06-16 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas. |
| EP2397123A1 (en) * | 2006-07-07 | 2011-12-21 | Aarhus Universitet | Nanoparticles for nucleic acid delivery |
| US20100150960A1 (en) * | 2006-09-22 | 2010-06-17 | The United States Of America, As Represented By The Secretary,Department Of Health And Human Servi | Compositions and methods for chitosan enhanced immune response |
| US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
| CN104703584B (zh) * | 2012-02-28 | 2019-05-31 | 艾塞尤提卡控股公司 | 可吸入药物组合物 |
-
2015
- 2015-05-12 WO PCT/EP2015/000974 patent/WO2015185180A1/en not_active Ceased
- 2015-05-12 CN CN201580030088.4A patent/CN106456746B/zh active Active
- 2015-05-12 CA CA2951063A patent/CA2951063C/en active Active
- 2015-05-12 ES ES15722448T patent/ES2754507T3/es active Active
- 2015-05-12 US US15/316,709 patent/US10369217B2/en active Active
- 2015-05-12 EP EP15722448.6A patent/EP3151856B1/en active Active
- 2015-05-12 JP JP2016571251A patent/JP6730937B2/ja active Active
- 2015-05-12 AU AU2015271295A patent/AU2015271295B2/en active Active
- 2015-06-05 AR ARP150101789A patent/AR100745A1/es unknown
-
2016
- 2016-12-04 IL IL249357A patent/IL249357B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017516834A5 (cg-RX-API-DMAC7.html) | ||
| Matalqah et al. | Chitosan nanoparticles as a novel drug delivery system: a review article | |
| JP4765020B2 (ja) | 陰イオン性多糖類を含むインサイチュゲルでの生理学的な薬剤の送達 | |
| Dua et al. | Application of chitosan and its derivatives in nanocarrier based pulmonary drug delivery systems | |
| JP2012176990A5 (cg-RX-API-DMAC7.html) | ||
| CN104013955A (zh) | 一种不含表面活性剂的水包油乳液及其用途 | |
| JP2008542342A5 (cg-RX-API-DMAC7.html) | ||
| CN106456746B (zh) | 用于免疫疗法的抗原负载壳聚糖纳米颗粒 | |
| Hou et al. | Up-to-date vaccine delivery systems: robust immunity elicited by multifarious nanomaterials upon administration through diverse routes | |
| CN102688195A (zh) | 一种具有pH敏感性的包载盐酸阿霉素的壳聚糖羧甲基壳聚糖纳米缓释微粒的制备方法 | |
| Junter et al. | Polysaccharides against viruses: Immunostimulatory properties and the delivery of antiviral vaccines and drugs | |
| CN103319733B (zh) | 一种微乳液制备壳聚糖-阴离子多糖复合物纳米微球的方法 | |
| CN102408488B (zh) | 季铵型阳离子淀粉基因控释载体材料及其制备方法和应用 | |
| He et al. | Surface-engineered Polygonatum sibiricum polysaccharide CaCO3 microparticles as novel vaccine adjuvants to enhance immune response | |
| Xiang et al. | Nanoparticles, immunomodulation and vaccine delivery | |
| Dowdall et al. | β‐1, 3 Glucan Microparticles & Nanoparticles: Fabrication Methods & Applications in Immunomodulation & Targeted Drug Delivery | |
| Zarifpour et al. | Preparation and characterization of trimethyl chitosan nanospheres encapsulated with tetanus toxoid for nasal immunization studies | |
| Elmowafy et al. | Polysaccharide-based platforms for nasal delivery: design, features, and perspectives | |
| CN115337272A (zh) | 一种天然多糖基化学-物理双交联水凝胶微粒及其制备与应用 | |
| Mogoşanu et al. | Pharmaceutical natural polymers: structure and chemistry | |
| CN101804031A (zh) | 一种利巴韦林-壳聚糖季铵盐纳米微粒的制备方法 | |
| Sandri et al. | Opportunities offered by chitosan-based nanotechnology in mucosal/skin drug delivery | |
| Liu et al. | Polymeric nanoparticles engineered as a vaccine adjuvant-delivery system | |
| Tafaghodi et al. | Original Research Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethylchitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate | |
| Velásquez | Chitosan-based nanomaterials on controlled bioactive agents delivery: a review |